Loading...
 
Mediterr J Rheumatol 2023;34(2):269-70
Chilblain Lupus
Authors Information

1St. Sebastian Visitation Hospital, Cherthala, Kerala, India

2Department of Clinical Immunology and Rheumatology, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India

3Department of Clinical Immunology and Rheumatology, Institute of Neurosciences, Kolkata, West Bengal, India

4Department of Clinical Immunology and Rheumatology, North Bengal Medical College, Darjeeling, West Bengal, India

Abstract
This paper has no abstract.

Cite this article as: Vinister GV, Roongta R, Sinha D, Chattopadhyay A, Mondal S. Chilblain Lupus. Mediterr J Rheumatol 2023;34(2):269-70,

Article Submitted: 26 May 2022; Revised Form: 20 Jun 2022; Article Accepted: 3 Jul 2022; Available Online: 30 Jun 2023

https://doi.org/10.31138/mjr.34.2.269

This work is licensed under a Creative Commons Attribution 4.0 International License.

©2023 The Author(s).